Previous 10 | Next 10 |
Gainers: Ocugen (OCGN) +230%.ARYA Sciences Acquisition (ARYA) +101%.CRH Medical (CRHM) +81%.BSQUARE (BSQR) +72%.Esports Entertainment (GMBL) +51%.Outlook Therapeutics (OTLK) +50%.Aeterna Zentaris (AEZS) +46%.Westport Fuel Systems (WPRT) +43%.Nxt-ID (NXTD) +37%.OrganiGram (OGI) +37%....
Erytech Pharma's (ERYP) Phase 3 clinical trial TRYbeCA-1, evaluating eryaspase in second-line pancreatic cancer will continue without modification following a planned interim superiority analysis conducted by an Independent Data Monitoring Committee ((IDMC)). The interim analysis was triggere...
ERYTECH Pharma (ERYP) has announced that the first patient was enrolled in an early-stage investigator-sponsored trial for its lead asset Eryaspase in first-line pancreatic cancer.The single-arm, multi-center, open-label Phase 1 trial, initiated and sponsored by Georgetown University, Wa...
A total of 510 patients enrolled Events required to trigger interim superiority analysis accrued Interim superiority analysis expected in Q1 2021; final analysis in Q4 2021 LYON, France and CAMBRIDGE, Mass., Dec. 14, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nas...
LYON, France and CAMBRIDGE, Mass., Dec. 10, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announce d...
W ebcast today, Monday, December 7 at 4:00 pm CET/10:00 am ET The study confirms the potential of eryaspase as an attractive treatment option for ALL patients with hypersensitivity to PEG-asparaginase LYON, France and CAMBRIDGE, Mass., Dec. 07, 2020 (...
LYON, France and CAMBRIDGE, Mass., Dec. 03, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announce...
LYON, France and CAMBRIDGE, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Nasdaq & Euronext: ERYP), announced t o day that its CEO, Gil Beyen, will present an update at the Jefferies Virtual London Healthcare Conference at 12 :00 pm EST / 05:...
ERYTECH Pharma S.A. (ERYP) Q3 2020 Earnings Conference Call November 6, 2020, 8:30 am ET Company Participants Gil Beyen - CEO Iman El-Hariry - CMO Eric Soyer - CFO & COO Conference Call Participants Justin Walsh - JMP Securities Philippa Gardner - Jefferies Ingrid Gafanhão - Kempen F...
Erytech Pharma (ERYP): 9M net loss of €53.6MCash and cash equivalents of €40.5M.Press Release For further details see: Erytech Pharma reports 9M results
News, Short Squeeze, Breakout and More Instantly...
Erytech Pharma S.A. Company Name:
ERYP Stock Symbol:
NASDAQ Market:
2023-05-09 09:56:46 ET A French %Biotech company is making some major waves so far during Tuesday’s session after it was announced that the company and Pherecydes intend to merge their operations and relocate all teams to the company’s Lyon location. The merger is set to c...
What to Know About Buying Penny Stocks on April 25th With another day of trading penny stocks here, there is a lot for investors to consider. Now, with so much going on in the stock market in the past few months, investors should be used to a high level of volatility. [Read More] ...